IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Content-Transfer-Encoding:
7bit
Sender:
Information and Referral and Internet Sightings <[log in to unmask]>
Subject:
Seroquel approved for Dx of bipolar disorder
From:
Sylvia Caras <[log in to unmask]>
Date:
Mon, 19 May 2008 08:06:55 -0700
Content-Type:
text/plain; charset=ISO-8859-1; format=flowed
MIME-Version:
1.0
Reply-To:
[log in to unmask]
Parts/Attachments:
text/plain (13 lines) 
AstraZeneca's Seroquel Given FDA Approval for Treating Patients with 
Bipolar Disorder
 From Associated Press WorldStream - May 14, 2008
LONDON--AstraZeneca PLC said Wednesday that U.S. regulators have 
approved its anti-psychotic drug Seroquel as a maintenance treatment for 
patients with bipolar I disorder. Seroquel, already on sale to treat 
schizophrenia and depressive or manic episodes, is AstraZeneca's 
second-biggest selling drug, generating US$4 billion of sales in 2007, 
but it is facing strong potential generic competition.


"People Who experience mood swings, fear, voices and visions"

ATOM RSS1 RSS2